NTT DATA to Acquire Chainalytics, Strengthening Its Supply Chain Consulting and Analytics Capabilities

PLANO, Texas--(BUSINESS WIRE)--#consulting--NTT DATA Services, a global digital business and IT services leader, today announced…

American Airlines Group Inc. Adopts Tax Benefit Preservation Plan for Net Operating Losses

FORT WORTH, Texas, Dec. 22, 2021 (GLOBE NEWSWIRE) -- American Airlines Group Inc. (the “Company”…

EXL publishes second annual Sustainability Report

NEW YORK, Dec. 22, 2021 (GLOBE NEWSWIRE) -- EXL (NASDAQ: EXLS), a leading global analytics…

Curia Unveils Comprehensive mRNA Solution

Curia’s mRNA Services Combine Comprehensive Experience and Flexible Capabilities from Discovery Through Fill-Finish Manufacturing ALBANY,…

Enfusion and Coinbase to Bring Seamless Digital Asset Connectivity to Institutions

-Coinbase Chooses Enfusion for First OEMS Connectivity- NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion,…

H.E. Justin Sun, Ambassador, Founder of TRON, and Winner of the Blue Origin Auction, Is Taking Five Crewmates with Him to Space Through the “Sea of Stars” Campaign

GENEVA, Switzerland--(BUSINESS WIRE)--H.E. Justin Sun, Ambassador, Permanent Representative of Grenada to the WTO & Founder…

Zai Lab Announces Promotion of Harald Reinhart, M.D. to President and Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Zai Lab…

Rimkus Consulting Group, Inc. Acquires Capital Consulting International

Global consulting firm sizably increases international footprint in the United Kingdom, Middle East, and Asia-Pacific…

Ligand’s Partner CStone Pharmaceuticals Receives Approval in China for Sugemalimab (Cejemly®) for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer in Combination with Chemotherapy

Sugemalimab was discovered using the OmniAb platform EMERYVILLE, Calif.--(BUSINESS WIRE)--$LGND--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today…

TandemAI Announces $25 Million Seed & Pre-series A Financing Led by OrbiMed and Chengwei Capital

Funding to advance the company’s proprietary, industry-leading, computational platform and support expansion of wet lab…